MEDI posts record Q3 revenue and 55.7% EBIT growth
MEDI reported record third-quarter sales of NOK 210m and 55.7% EBIT growth, approved a new quarterly dividend and targets a vascular INTUI launch in H1 2027.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
According to TradingView, MEDI recorded record third-quarter sales of NOK 210m, while EBIT climbed 55.7%. The company attributed the result to strong demand for its own products and imaging solutions.
Year-to-date revenue exceeded NOK 600m. Management approved a new quarterly dividend and set a goal to bring the vascular INTUI product to market in the first half of 2027.
why it matters
For investors this points to solid profit growth at a small medtech issuer, and regular payouts may draw attention to the stock. The INTUI launch in 2027 is the next key milestone to watch.
tags
instruments
sources
- MEDI: Record Q3 revenue and 55.7% EBIT growth, with vascular INTUI targeted for H1 2027 — TradingView, 23 October 2026 at 08:51 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗